{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T13:08:40Z","timestamp":1773407320006,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T00:00:00Z","timestamp":1374019200000},"content-version":"vor","delay-in-days":472,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.seizure.2011.12.010","type":"journal-article","created":{"date-parts":[[2012,1,30]],"date-time":"2012-01-30T04:41:06Z","timestamp":1327898466000},"page":"202-204","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Lacosamide treatment of juvenile myoclonic epilepsy"],"prefix":"10.1016","volume":"21","author":[{"given":"Pegah","family":"Afra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bola","family":"Adamolekun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.seizure.2011.12.010_bib0005","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/01.wco.0000162856.75391.b1","article-title":"Mechanisms, genetics, and pathogenesis of juvenile myoclonic epilepsy","volume":"18","author":"Zifkin","year":"2005","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.seizure.2011.12.010_bib0010","series-title":"Epilepsy: a comprehensive textbook","first-page":"2455","article-title":"Juvenile myoclonic epilepsy","author":"Kobayashi","year":"2008"},{"key":"10.1016\/j.seizure.2011.12.010_bib0015","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1600-0404.1985.tb00900.x","article-title":"Epilepsy with impulsive petit mal (juvenile myoclonic epilepsy)","volume":"72","author":"Janz","year":"1985","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.seizure.2011.12.010_bib0020","series-title":"Epileptic syndromes in infancy, childhood and adolescence","first-page":"367","article-title":"Juvenile myoclonic epilepsy","author":"Thomas","year":"2005"},{"key":"10.1016\/j.seizure.2011.12.010_bib0025","series-title":"Juvenile myoclonic epilepsy: the Janz syndrome","first-page":"11","article-title":"Juvenile myoclonic epilepsy today: current definitions and limits","author":"Genton","year":"2000"},{"key":"10.1016\/j.seizure.2011.12.010_bib0030","series-title":"Current practice of clinical electroencephalography","first-page":"506","article-title":"Seizures and epilepsy","author":"Pedley","year":"2003"},{"key":"10.1016\/j.seizure.2011.12.010_bib0035","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1136\/jnnp.70.2.240","article-title":"Clinical factors of drug resistance in juvenile myoclonic epilepsy","volume":"70","author":"Gelisse","year":"2001","journal-title":"J Neurol, Neurosurg Psychiatry"},{"key":"10.1016\/j.seizure.2011.12.010_bib0150","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/S0140-6736(07)60461-9","article-title":"The SANAD study of effectiveness of valproate, lamotrigine or topiramate for generalized and unclassifiable epilepsy: an unblinded randomized controlled trial","volume":"369","author":"Marson","year":"2007","journal-title":"Lancet"},{"issue":"Suppl. l.5","key":"10.1016\/j.seizure.2011.12.010_bib0045","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1528-1157.1998.tb05141.x","article-title":"Role of new and established antiepileptic drugs","volume":"39","author":"Leppik","year":"1998","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2011.12.010_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.reprotox.2009.02.014","article-title":"Valproic acid in pregnancy: how much are we endangering the embryo and fetus?","volume":"28","author":"Ornoy","year":"2009","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.seizure.2011.12.010_bib0055","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s11940-011-0131-z","article-title":"Treatment options in juvenile myoclonic epilepsy","volume":"13","author":"Mantoan","year":"2011","journal-title":"Curr Treat Options Neurol"},{"key":"10.1016\/j.seizure.2011.12.010_bib0060","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1212\/WNL.34.3.285","article-title":"Juvenile myoclonic epilepsy of Janz","volume":"34","author":"Delgado-Escueta","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2011.12.010_bib0065","unstructured":"Vimpat Approved in Europe. UCB, Inc. Press Release September 3, 2008. http:\/\/www.ucb.com\/news\/3606asp."},{"key":"10.1016\/j.seizure.2011.12.010_bib0070","unstructured":"UCB's Vimpat approved by U.S. FDA as adjunctive therapy for partial onset seizures in adults. UCB, Inc. Press Release October 29, 2008. http:\/\/www.ucb.com\/news\/3606asp."},{"key":"10.1016\/j.seizure.2011.12.010_bib0075","unstructured":"FDA places lacosamide in Schedule V. Press Release, June 22, 2009. http:\/\/health.cch.com\/spotlight\/food-drug-devices\/060109b.asp."},{"key":"10.1016\/j.seizure.2011.12.010_bib0080","doi-asserted-by":"crossref","first-page":"555","DOI":"10.2165\/00023210-200923070-00002","article-title":"Lacosamide: a new approach to target voltage-gated sodium currents in epileptic disorders","volume":"23","author":"Curia","year":"2009","journal-title":"CNS Drugs"},{"key":"10.1016\/j.seizure.2011.12.010_bib0085","unstructured":"Arnold S., Beige A. Adjunctive treatment with lacosamide: an option for generalized epilepsy? Abstract 2.206, 2010, American Epilepsy Society Annual Meeting. www.aesnet.org."},{"key":"10.1016\/j.seizure.2011.12.010_bib0090","series-title":"American Epilepsy Society Annual Meeting","article-title":"Role of lacosamide as adjunctive treatment of adults with primary generalized epilepsy. Abstract 2. 159","author":"Afra","year":"2010"},{"key":"10.1016\/j.seizure.2011.12.010_bib0155","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1212\/01.wnl.0000297512.18364.40","article-title":"Levetiracetam for the treatment of idiopathic generalized epilepsy with myoclonic seizures","volume":"70","author":"Noachtar","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2011.12.010_bib0100","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S1059-1311(03)00139-0","article-title":"Levetiracetam treatment of idiopathic generalized epilepsy","volume":"12","author":"Krauss","year":"2003","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2011.12.010_bib0105","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1600-0404.2010.01472.x","article-title":"Outcome of lamotrigine treatment in juvenile myoclonic epilepsy","volume":"124","author":"Bodenstein-Sachar","year":"2011","journal-title":"Acta Neurolog Scand"},{"key":"10.1016\/j.seizure.2011.12.010_bib0110","first-page":"187","article-title":"Our clinical experience with zonisamide in resistant generalized epilepsy syndromes","volume":"62","author":"Kelemen","year":"2011","journal-title":"Ideggyogy Sz"},{"issue":"Suppl. 3","key":"10.1016\/j.seizure.2011.12.010_bib0115","first-page":"S11","article-title":"Aggravation of generalized epilepsies","volume":"39","author":"Berkovic","year":"1998","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2011.12.010_bib0120","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1093\/brain\/awl047","article-title":"Absence and myoclonic status epilepticus precipitated by antiepileptic drugs in idiopathic generalized epilepsy","volume":"129","author":"Thomas","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.seizure.2011.12.010_bib0125","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1111\/j.0013-9580.2004.19704.x","article-title":"Worsening of seizures by oxcarbazepine in juvenile myoclonic generalized epilepsies","volume":"45","author":"Gelisse","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2011.12.010_bib0130","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0387-7604(99)00113-8","article-title":"When antiepileptic drugs aggravate epilepsy","volume":"22","author":"Genton","year":"2000","journal-title":"Brain Dev"},{"key":"10.1016\/j.seizure.2011.12.010_bib0135","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1212\/01.wnl.0000174517.21383.36","article-title":"Lamotrigine associated with exacerbation or de novo myoclonus in idiopathic generalized epilepsies","volume":"65","author":"Crespel","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2011.12.010_bib0140","series-title":"American Epilepsy Society Annual Meeting","article-title":"lacosamide in progressive myoclonic epilepsy type 1: a case report. Abstract 3. 108","author":"Polovitz","year":"2010"},{"key":"10.1016\/j.seizure.2011.12.010_bib0145","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/S1388-2457(01)00634-4","article-title":"Cortical myoclonus in Janz sundrome","volume":"112","author":"Panzica","year":"2001","journal-title":"Clin Neurophysiol"}],"container-title":["Seizure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131111003220?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131111003220?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T01:41:46Z","timestamp":1761010906000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131111003220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S1059131111003220"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2011.12.010","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lacosamide treatment of juvenile myoclonic epilepsy","name":"articletitle","label":"Article Title"},{"value":"Seizure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2011.12.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}